Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 10/20 | 0.67 |
| ▸ | PPARG | P37231 | 9/20 | 0.67 |
| ▸ | PPARD | Q03181 | 2/20 | 0.67 |
| ▸ | ACE | P12821 | 1/20 | 0.59 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.59 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.56 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.53 |
| ▸ | CTSS | P25774 | 3/20 | 0.53 |
| ▸ | CTSK | P43235 | 2/20 | 0.53 |
| ▸ | CTSL | P07711 | 1/20 | 0.53 |
| ▸ | CTSB | P07858 | 1/20 | 0.53 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.52 |
| ▸ | ITGAV | P06756 | 1/20 | 0.52 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12984836 | 0.94 | PPARA (0.74) | PPARAPPARGPPARDACEITGB3 | |
| SCHEMBL5065660 | 0.94 | PPARA (0.74) | PPARAPPARGPPARDACEITGB3 | |
| SCHEMBL9005835 | 0.94 | PPARA (0.74) | PPARAPPARGPPARDACEITGB3 | |
| SCHEMBL3923929 | 0.92 | ACE (0.65) | PPARAPPARGPPARDACEITGB3 | |
| SCHEMBL3923937 | 0.92 | ACE (0.65) | PPARAPPARGPPARDACEITGB3 | |
| SCHEMBL3925152 | 0.92 | ACE (0.65) | PPARAPPARGPPARDACEITGB3 | |
| SCHEMBL2290444 | 0.92 | ACE (0.65) | PPARAPPARGPPARDACEITGB3 | |
| SCHEMBL2292944 | 0.91 | PPARG (0.59) | PPARAPPARGPPARDACEITGB3 | |
| SCHEMBL2292947 | 0.91 | PPARG (0.59) | PPARAPPARGPPARDACEITGB3 | |
| SCHEMBL2289496 | 0.88 | PPARA (0.66) | PPARAPPARGPPARDACEITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7989480-B2 | Aryl amino acid derivatives as inhibitors for treating inflammation | DECODE GENETICS EHF (IS) | 2011-08-02 | — | — | US | disclosed |
| US-20080033024-A1 | ARYL AMINO ACID DERIVATIVES AS INHIBITORS FOR TREATING INFLAMMATION | DECODE GENETICS EHF. (IS) | 2008-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080033024-A1 | ARYL AMINO ACID DERIVATIVES AS INHIBITORS FOR TREATING INFLAMMATION | LTA4H, LTB4R2, LTB4R | PPARA 350/4885PPARG 410/4885PPARD 805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.